TargetRx is a clinical stage, high-tech pharmaceutical R&D company focused on developing next-generation targeted therapies for cancer patients, particularly those who are resistant or refractory to current treatments. TargetRx has developed a series of cutting-edge and efficient small molecule drug discovery platforms, which combine innovative research and development capabilities for drug design, screening, evaluation and optimization. Since its establishment, TargetRx has been granted over 170 patents from authorities in China, the US, Europe, Japan and other regions. Several potential best-in-class compounds are at different stages of multi-national clinical trials.
BD Contact: shujun.mai@tjrbiosciences.com.
Company Details
- Employees
- 12
- Founded
- -
- Address
- 15 Keyuan Rd., Nanshan District,, A1-301,china
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- HQ
- shenzhen, Guangdong
Shenzhen Targetrx, Inc. Questions
Shenzhen Targetrx, Inc.'s website is https://www.tjrbiosciences.com/en/
Shenzhen Targetrx, Inc.'s LinkedIn profile is https://cn.linkedin.com/company/shenzhen-targetrx
Shenzhen Targetrx, Inc. has
12 employees.
View email and phone details for 12
employees at Shenzhen Targetrx, Inc..
Shenzhen Targetrx, Inc.'s industry is
Pharmaceutical Manufacturing
Shenzhen Targetrx, Inc.'s top competitors are
Oncomatryx Biopharma,
89bio,
Atalanta Therapeutics,
Novatim Immune Therapeutics,
Lutris Pharma,
Akero Therapeutics,
Disc Medicine,
Ascentage Pharma,
Helicore Biopharma,
Hepion Pharmaceuticals.
Shenzhen Targetrx, Inc.'s categories are Pharmaceutical Manufacturing
Shenzhen Targetrx, Inc.'s founding year is 2014
